Literature DB >> 27001366

US Army blood program: 2025 and beyond.

Richard Gonzales1,2, Audra L Taylor2, Andrew J Atkinson3, Wilbur W Malloy4, Victor W Macdonald3, Andrew P Cap5.   

Abstract

In preparing to support the Army in 2025 and beyond, the Army Blood Program remains actively engaged with the research and advanced development of blood products and medical technology to improve blood safety and efficacy in conjunction with the US Army Medical Research and Materiel Command. National and International Blood Bank authorities have noted that the US Army research and development efforts in providing new blood products and improving blood safety operate on the cutting edge of technology and are transformational for the global blood industry. Over the past 14 years, the Army has transformed how blood support is provided and improved the survival rate of casualties. Almost every product or process developed by or for the military has found an application in treating civilian patients. Conflicts have many unwanted consequences; however, in times of conflict, one positive aspect is the identification of novel solutions to improve the safety and efficacy of the blood supply.
© 2015 AABB.

Entities:  

Mesh:

Year:  2016        PMID: 27001366     DOI: 10.1111/trf.13338

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  2 in total

1.  Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 (Commentary, p. 3026).

Authors:  Chintamani Atreya; Simone Glynn; Michael Busch; Steve Kleinman; Edward Snyder; Sara Rutter; James AuBuchon; Willy Flegel; David Reeve; Dana Devine; Claudia Cohn; Brian Custer; Raymond Goodrich; Richard J Benjamin; Anna Razatos; Jose Cancelas; Stephen Wagner; Michelle Maclean; Monique Gelderman; Andrew Cap; Paul Ness
Journal:  Transfusion       Date:  2019-05-29       Impact factor: 3.157

2.  Effect of phase-change material blood containers on the quality of red blood cells during transportation in environmentally-challenging conditions.

Authors:  Xiaoyang Yi; Minxia Liu; Jiexi Wang; Qun Luo; Hailong Zhuo; Shaoduo Yan; Donggen Wang; Ying Han
Journal:  PLoS One       Date:  2020-01-29       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.